This report from Life Science Intelligence provides the latest market data for the Global Transcatheter Aortic Valve Replacement/Implantation (TAVR/TAVI) Market. Information covered by this report includes:
This report covers the impact of COVID-19 on heart valve replacement procedures, including a recent forecast from 2020 to 2025. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Medtronic, Edwards Lifesciences, and others. The report provides insights into trends, drivers, and limiters of the transcatheter aortic heart valves market, as well as highlights potential opportunities.
Boston Scientific/Symetis
Direct Flow Medical
Edwards Lifesciences
JenaValve
Medtronic
NVT
Portico
Transcatheter Technologies
Trusted By The Companies Pioneering What’s Next
Market Intelligence
Schedule an exploratory call
Request Info17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy